Deborah M Mullen1, Thomas J Marr. 1. HealthPartners, Health Informatics, Bloomington, Minnesota 55425, USA. Deborah.M.Mullen@HealthPartners.com
Abstract
BACKGROUND: To assess the effect of gastric bypass surgery on the total cost of medical care for morbidly obese members compared with obese members and a general population. METHODS: We used an observational pre-post test design to analyze the administrative claim records of 224 gastric bypass patients during 3 periods (preoperative, surgical, and postoperative years) for a total of 7.5 years. The estimated future care costs for gastric bypass patients were determined from their preoperative cost trends, adjusting for the annualized actuarial trends. The general membership population actuarial trends and overweight/obese member medical expenditure data were used as comparison groups. RESULTS: The inflation adjusted mean per member per year total paid decreased by $1895 in the fifth year after surgery. The mean costs for gastric bypass patients were lower within the first year after surgery than their preoperative costs. At 3.5 years after surgery, the surgical costs had been recouped for patients undergoing gastric bypass surgery, and by year 2, they had incurred fewer costs than the obese health plan population. CONCLUSION: Although gastric bypass is a costly surgical procedure, the longitudinal costs savings and overall health improvement for patients undergoing gastric bypass surgery are cost-effective within a closed, experienced network. Weight loss surgery decreased the annual costs per patient in the years after surgery. The costs were slightly elevated in the fifth year after surgery because of maternity cases and orthopedic surgeries.
BACKGROUND: To assess the effect of gastric bypass surgery on the total cost of medical care for morbidly obese members compared with obese members and a general population. METHODS: We used an observational pre-post test design to analyze the administrative claim records of 224 gastric bypass patients during 3 periods (preoperative, surgical, and postoperative years) for a total of 7.5 years. The estimated future care costs for gastric bypass patients were determined from their preoperative cost trends, adjusting for the annualized actuarial trends. The general membership population actuarial trends and overweight/obese member medical expenditure data were used as comparison groups. RESULTS: The inflation adjusted mean per member per year total paid decreased by $1895 in the fifth year after surgery. The mean costs for gastric bypass patients were lower within the first year after surgery than their preoperative costs. At 3.5 years after surgery, the surgical costs had been recouped for patients undergoing gastric bypass surgery, and by year 2, they had incurred fewer costs than the obese health plan population. CONCLUSION: Although gastric bypass is a costly surgical procedure, the longitudinal costs savings and overall health improvement for patients undergoing gastric bypass surgery are cost-effective within a closed, experienced network. Weight loss surgery decreased the annual costs per patient in the years after surgery. The costs were slightly elevated in the fifth year after surgery because of maternity cases and orthopedic surgeries.
Authors: Guido H H Mannaerts; Rowaa E A Allatif; Fatima Y Al Hashmi; Arati Bhosale; Ahmad N Hammo; Sujoud H Isied; Warda A Qureshi; Omar S Al Hamad; Yasser Kayyal; Hmouda S T Al Afari Journal: Obes Surg Date: 2019-07 Impact factor: 4.129
Authors: Sarah B Cairo; Indrajit Majumdar; Aurora Pryor; Alan Posner; Carroll M Harmon; David H Rothstein Journal: Obes Surg Date: 2018-04 Impact factor: 4.129
Authors: Charles M Yarborough; Stacy Brethauer; Wayne N Burton; Raymond J Fabius; Pamela Hymel; Shanu Kothari; Robert F Kushner; John Magaña Morton; Kathryn Mueller; Nicolaas P Pronk; Mitchell S Roslin; David B Sarwer; Brian Svazas; Jeffrey S Harris; Garrett I Ash; Jamie T Stark; Marianne Dreger; Julie Ording Journal: J Occup Environ Med Date: 2018-01 Impact factor: 2.162
Authors: Amarpreet S Chawla; Chia-Wen Hsiao; Martha C Romney; Ricardo Cohen; Francesco Rubino; Philip Schauer; Pierre Cremieux Journal: Pharmacoeconomics Date: 2015-07 Impact factor: 4.981
Authors: Jean-Eric Tarride; Aristithes G Doumouras; Dennis Hong; J Michael Paterson; Semra Tibebu; Richard Perez; Julia Ma; Valerie H Taylor; Feng Xie; Vanessa Boudreau; Eleanor Pullenayegum; David R Urbach; Mehran Anvari Journal: JAMA Surg Date: 2020-09-16 Impact factor: 14.766